ASP-2205
- Generic Name
- ASP-2205
A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2205 in Healthy Young Males and Females and Elderly Females and to Evaluate the Effect of Food on the Pharmacokinetics of a Single Dose of of ASP2205
Phase 1
Terminated
- Conditions
- Pharmacokinetics of ASP2205Healthy Subjects
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-12-11
- Last Posted Date
- 2016-06-21
- Lead Sponsor
- Astellas Pharma Europe B.V.
- Target Recruit Count
- 93
- Registration Number
- NCT02314793
- Locations
- 🇬🇧
Site GB44001, Harrow, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath